1218.40.81003 Boehringer Ingelheim Investigational Site

Suita, Osaka,

0 studies enrolling now · 1 studies all time

What they study most

Diabetes Mellitus, Type 2

Studies at this site

• Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM — Completed